A General Court ruling announced Tuesday has said that the European Commission was wrong to deny MasterCard access to documents related to a study on the cost of using bank cards, a ruling that some say is likely to have broader implications in future competition cases in transparency disputes.
Reports say the General Court found that the Commission could not claim that the documents were related to an antitrust investigation. It was a win for MasterCard as the credit card conglomerate faces a larger ruling by the European Court of Justice later this week as it fights proposed caps on cross-boarder interchange fees as proposed by the Commission.
European Commissioner Joaquin Almunia said the Commission would fully examine Tuesday’s decision and the consequences it would have for granting or denying access to its documents. The regulator will now have to adopt a decision for a procedure to do so that is in in line with the General Court’s order.
The Commission said that the full report involving the documents in question, which studies the cost burden on retailers that accept payment by card or cash, will likely be released in the coming weeks. The Commission could appeal the ruling to the EU Court of Justice.
The EU’s highest court is set to determine Thursday the fate of MasterCard’s challenge to a 2007 ruling that ordered the credit card company to limit its cross-boarder interchange fees, which were found to harm competition.
Full content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas